Under the terms of the agreement, Frutarom USA will be responsible for all sales and marketing, warehousing and distribution activities in North America, while BLIS Technologies remains focused on further product development efforts and activities with its key research partner, The University of Otago (New Zealand).
BLIS K12 is a probiotic specifically designed to protect the entire oral cavity, including the throat, mouth gums and teeth, and under certain circumstances, it has even been shown to protect the nasal sinus from infection. BLIS K12 will produce a bacteriocin when it is under threat from a potential pathogen. This makes BLIS K12 hundreds of times more effective than a traditional antiseptic throat lozenge, BLIS notes.